Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Return on Assets (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Return on Assets for 4 consecutive years, with 1.02% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 24.0% to 1.02% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.02%, a 24.0% decrease, with the full-year FY2024 number at 0.71%, down 21.0% from a year prior.
  • Return on Assets was 1.02% for Q3 2025 at Orchestra BioMed Holdings, up from 1.37% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.26% in Q1 2023 to a low of 1.37% in Q2 2025.
  • A 4-year average of 0.66% and a median of 0.65% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: dropped -19bps in 2023, then tumbled -65bps in 2025.
  • Orchestra BioMed Holdings' Return on Assets stood at 0.29% in 2022, then plummeted by -68bps to 0.48% in 2023, then crashed by -68bps to 0.8% in 2024, then decreased by -26bps to 1.02% in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Return on Assets are 1.02% (Q3 2025), 1.37% (Q2 2025), and 0.98% (Q1 2025).